AzTrials
AzTrials

InsomniaNCT05826002

Optimization of a Digital Self-guided Psychological Intervention for Insomnia: A Randomized Factorial Experiment

A study testing Digital self-guided psychological intervention for insomnia in people with Insomnia, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In a previous pilot study, a digital self-guided intervention for insomnia showed preliminary positive effects on insomnia symptoms. In order to optimize the digital self-guided format, this study will evaluate the added value of three treatment features on treatment engagement and insomnia symptoms. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Insomnia
What is being tested?
Digital self-guided psychological intervention for insomnia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
447 participants
Where
1 siteSweden
Study dates
1 May 2023to 15 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥ 18 years of age.
  • ≥ 15 points on Insomnia Severity Index.
  • Insomnia diagnosis, according to criteria in the Diagnostic and Statistical Manual of mental disorders-5 (somatic/psychiatric comorbidity is allowed).
  • Good understanding of the Swedish language.
  • No practical obstacles to participate in treatment and assessments.
  • Daily access to computer/smart-phone/tablet with Internet access.
  • Can receive phone calls and text messages during the study period.

Who cannot join

  • Sleep diseases, such as narcolepsy or sleep apnea.
  • Somatic or psychiatric illnesses that either are directly contraindicated for the treatment, require other treatment, or entail symptoms/a functional level making it too difficult to participate in the study.
  • Alcohol/drug abuse, or medication with side effects on sleep (however, sleep medication is allowed).
  • Working nights or night shifts.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Centre for Psychiatry Research

    Stockholm

Other trials in Sweden

About this study

In a previous pilot study, a digital self-guided intervention for insomnia showed preliminary positive effects on insomnia symptoms. In order to optimize the digital self-guided format, this study will evaluate the added value of three treatment features on treatment engagement and insomnia symptoms. The participants will be adults with insomnia. The trial will be a 2x2x2 randomized factorial experiment, where the following features/factors will be manipulated: an optimized graphical user interface (yes or no), an adaptive treatment strategy (yes or no), and daily prompts to use the intervention (yes or no). The factorial experiment will create 8 equally large groups (1:1:1:1:1:1:1:1), who will receive the different combinations of features. The main outcome will be the effect on treatment engagement.

Conditions
Insomnia
Being tested
Digital self-guided psychological intervention for insomnia
Keywords
Insomnia, ICBT, Factorial Experiment, Optimization, User Interface, Adaptive Treatment Strategy, Prompts, Digital Intervention
Medical subject headings
Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digital self-guided psychological intervention for insomniaBehavioural

    A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

Study groups in NCT05826002
Study groupRoleWhat they receive
Digital insomnia interventionActive comparatorThis group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (no).
Receives: Behavioral: Digital self-guided psychological intervention for insomnia
Digital insomnia intervention + optimized user interfaceActive comparatorThis group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (no).
Receives: Behavioral: Digital self-guided psychological intervention for insomnia
Digital insomnia intervention + adaptive treatment strategyActive comparatorThis group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (no).
Receives: Behavioral: Digital self-guided psychological intervention for insomnia
Digital insomnia intervention + optimized user interface, adaptive treatment strategyActive comparatorThis group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (no).
Receives: Behavioral: Digital self-guided psychological intervention for insomnia
Digital insomnia intervention + daily promptsActive comparatorThis group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (yes).
Receives: Behavioral: Digital self-guided psychological intervention for insomnia
Digital insomnia intervention + optimized user interface, daily promptsActive comparatorThis group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (yes).
Receives: Behavioral: Digital self-guided psychological intervention for insomnia
Digital insomnia intervention + adaptive treatment strategy, daily promptsActive comparatorThis group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (yes).
Receives: Behavioral: Digital self-guided psychological intervention for insomnia
Digital insomnia intervention + optimized user interface, adaptive treatment strategy, daily promptsActive comparatorThis group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (yes).
Receives: Behavioral: Digital self-guided psychological intervention for insomnia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Engagement with intervention method

    Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better

    Measured: Up to 12 months after treatment

  2. Engagement with intervention method

    Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better

    Measured: Immediately after treatment (4 weeks after treatment start)

Secondary outcomes (13)
  1. Change in Insomnia symptoms

    Insomnia Severity Index (self-rated), score range 0-28, lower is better

    Measured: Change from baseline (right before treatment start) up to 12 months after treatment

  2. Change in Insomnia symptoms

    Insomnia Severity Index (self-rated), score range 0-28, lower is better

    Measured: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  3. Change in Depression symptoms

    Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better

    Measured: Change from baseline (right before treatment start) up to 12 months after treatment

  4. Change in Depression symptoms

    Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better

    Measured: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  5. Change in Anxiety symptoms

    Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better

    Measured: Change from baseline (right before treatment start) up to 12 months after treatment

  6. Change in Anxiety symptoms

    Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better

    Measured: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  7. Change in Life quality

    Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better

    Measured: Change from baseline (right before treatment start) up to 12 months after treatment

  8. Change in Life quality

    Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better

    Measured: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  9. Change in Daily function

    World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better

    Measured: Change from baseline (right before treatment start) up to 12 months after treatment

  10. Change in Daily function

    World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better

    Measured: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)

  11. Treatment credibility

    Credibility/Expectancy Questionnaire (self-rated), score range 0-50, higher is better

    Measured: 2 weeks after treatment start (mid-treatment)

  12. Intervention/system usability

    System Usability Scale (self-rated), score range 0-100, higher is better

    Measured: 2 weeks after treatment start (mid-treatment)

  13. Treatment satisfaction

    Client Satisfaction Questionnaire-8 (self-rated), score range 8-32, higher is better

    Measured: Immediately after treatment (4 weeks after treatment start)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2023
  2. Study start1 May 2023
  3. Primary completion15 Dec 2024
  4. Study completion15 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
A 2x2x2 randomized factorial experiment, where adult participants with insomnia get to use a digital self-guided intervention for insomnia. Three factors/treatment features will be manipulated in the experiment, namely: 1) an optimized graphical user interface (yes or no), 2) an adaptive treatment strategy (yes or no), and 3) daily prompts to use the intervention (yes or no). The factorial experiment will create 8 equally large groups (1:1:1:1:1:1:1:1), who will receive the different combinations of features.
Masking
Single blind
Who is masked
Participant
Enrolment
447 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05826002
Sponsor's protocol ID
2022-07226-01
Status last verified
Mar 2025
First submitted
27 Mar 2023
Last updated
12 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: IPD available anonymized on reasonable request.

Publications

  • Hentati A, Hentati Isacsson N, Rosen A, Jernelov S, Kaldo V, Ljotsson B, Forsell E, Lindefors N, Kraepelien M. Effects of intervention design on engagement and outcomes in digital self-help for insomnia - factorial RCT. NPJ Digit Med. 2025 Jul 8;8(1):416. doi: 10.1038/s41746-025-01839-0.

    PubMed 40628992

Questions about this trial

What is this clinical trial studying?

A study testing Digital self-guided psychological intervention for insomnia in people with Insomnia, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Engagement with intervention method (time frame: Up to 12 months after treatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05826002, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in